Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 11(3): e0149987, 2016.
Article in English | MEDLINE | ID: mdl-26930631

ABSTRACT

Previous research has found that adolescent ethanol (EtOH) exposure alters drug seeking behaviors, cognition and neuroplasticity. Using male Sprague Dawley rats, differences in spatial working memory, non-spatial discrimination learning and behavioral flexibility were explored as a function of age at the onset (mid-adolescent vs. adult) of chronic EtOH exposure (CET). Concentrations of mature brain-derived neurotrophic factor (mBDNF) and beta-nerve growth factor (ß-NGF) in the prefrontal cortex and hippocampus were also assessed at different time-points: during CET, following acute abstinence (48-hrs), and after protracted abstinence (6-8 wks). Our results revealed that an adolescent onset of CET leads to increased EtOH consumption that persisted into adulthood. In both adult and adolescent onset CET groups, there were significant long-term reductions in prefrontal cortical mBDNF and ß-NGF levels. However, only adult onset CET rats displayed decreased hippocampal BDNF levels. Spatial memory, assessed by spontaneous alternation and delayed alternation, was not significantly affected by CET as a function of age of drinking onset, but higher blood-EtOH levels were correlated with lower spontaneous alternation scores. Regardless of the age of onset, EtOH exposed rats were impaired on non-spatial discrimination learning and displayed inflexible behavioral patterns upon reversal learning. Our results indicate that adolescent EtOH exposure changes long-term consumption patterns producing behavioral and neural dysfunctions that persist across the lifespan.


Subject(s)
Alcohol Drinking , Behavior, Animal/drug effects , Ethanol/pharmacology , Nerve Growth Factors/metabolism , Age Factors , Animals , Behavior, Animal/physiology , Brain-Derived Neurotrophic Factor/metabolism , Central Nervous System Depressants/pharmacology , Ethanol/administration & dosage , Hippocampus/drug effects , Hippocampus/metabolism , Male , Prefrontal Cortex/drug effects , Prefrontal Cortex/metabolism , Rats, Sprague-Dawley , Spatial Learning/drug effects , Spatial Learning/physiology , Time Factors , Weight Gain/drug effects , Weight Gain/physiology
2.
Exp Clin Psychopharmacol ; 21(5): 416-25, 2013 Oct.
Article in English | MEDLINE | ID: mdl-24099361

ABSTRACT

The effects of cannabinoid CB1 agonists (including Δ9-tetrahydrocannabinol, the main psychoactive component of marijuana) on attention are uncertain, with reports of impairments, no effects, and occasionally performance enhancements. To better understand these effects, we sought to uncover a role of changing online (within-session) strategy as a possible mediator of the effects of the novel, potent CB1 agonist AM 4054, on a model of sustained attention in male Sprague-Dawley rats. In this operant, two-choice reaction time (RT) task, AM 4054 decreased accuracy in an asymmetric manner; that is, performance was spared on one lever but impaired on the other. Furthermore, this pattern was enhanced by the outcome of the previous trial such that AM 4054 strengthened a win-stay strategy on the "preferred" lever and a lose-shift strategy on the "nonpreferred" lever. This pattern is often found in tests of expectancy; therefore, in a second experiment AM 4054 enhanced expectancy that we engendered by altering the probability of the two stimulus cues. Accuracy was impaired in reporting the less frequent cue, but only after two or more presentations of the more frequent cue. Taking the results of the experiments together, AM 4054 engendered expectancy by increasing the role of previous trial location and outcome on performance of future trials, diminishing stimulus control (and therefore, accuracy). This novel effect of CB1 receptor agonism may contribute to the deleterious effects of cannabinoids on attention.


Subject(s)
Adamantane/analogs & derivatives , Attention/drug effects , Cannabinoid Receptor Agonists/pharmacology , Cannabinol/analogs & derivatives , Receptor, Cannabinoid, CB1/agonists , Vision, Ocular/drug effects , Adamantane/pharmacology , Animals , Cannabinol/pharmacology , Conditioning, Operant/drug effects , Cues , Male , Rats , Reaction Time/drug effects , Uncertainty , Vision, Ocular/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...